Epilepsy trials in United States
208 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- No phaseEnrolling by invitationAn Examination of Cognitive and Sensorimotor Processes in Patients With Epilepsy
- Where
- Great Neck
- Age
- 5 years and over
- People
- 450
- Run by
- Northwell Health
See details and how to joinNCT00859794 - No phaseTaking peopleSurgery as a Treatment for Medically Intractable Epilepsy
- Where
- Bethesda
- Age
- 8 years to 99 years
- People
- 300
- Run by
- National Institute of Neurological Disorders and Stroke (NINDS)
See details and how to joinNCT01273129 - No phaseTaking peopleInvestigating Epilepsy: Screening and Evaluation
- Where
- Bethesda
- Age
- 8 years to 110 years
- People
- 1,000
- Run by
- National Institute of Neurological Disorders and Stroke (NINDS)
See details and how to joinNCT03478852 - No phaseTaking peopleOptimizing Brain Stimulation Parameters
- Where
- Rochester
- Age
- 6 years and over
- People
- 30
- Run by
- Mayo Clinic
See details and how to joinNCT06617845 - No phaseTaking peopleDiagnosing Epilepsy To EffeCT Change
- Where
- Ann Arbor, Billings, Birmingham, Boston, Charlotte, Clevland, Dallas, Durham, Houston, Indianapolis, Irvine, Jacksonville, Miami, Minneapolis, New Haven, Palo Alto, Philadelphia, Phoenix, Rochester, San Diego, St Louis, Tampa
- Age
- 18 years to 75 years
- People
- 210
- Run by
- Epiminder America, Inc.
See details and how to joinNCT07110337 - Phase 1/2Taking peopleA Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
- Where
- Ann Arbor, Aurora, Chicago, Columbus, Durham, Fort Worth, Miami, New York, Portland, Rochester, San Francisco
- Age
- 6 months to 17 years
- People
- 113 worldwide
- Run by
- Encoded Therapeutics
See details and how to joinNCT05419492 - No phaseTaking peopleDiagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
- Where
- Ann Arbor, Billings, Birmingham, Boston, Charlotte, Cleveland, Durham, Indianapolis, Jacksonville, Miami, Minneapolis, New Haven, Palo Alto, Philadelphia, Phoenix, Rochester, San Diego, St Louis, Tampa
- Age
- 18 years to 75 years
- People
- 210
- Run by
- Epiminder America, Inc.
See details and how to joinNCT07110454 - Phase 4Not yet taking people in United StatesA Study to Investigate the Effect of Gradual Titration to Optimize Cannabidiol Treatment in Adults With LGS
- Where
- Fresno, New Orleans, Raleigh
- Age
- 18 years and over
- People
- 40
- Run by
- Jazz Pharmaceuticals
See details and how to joinNCT07728097 - No phaseTaking peopleEXercise-induced PhysioLogical Adaptations In Neurological Disorders
- Where
- Boston
- Age
- 18 years and over
- People
- 240
- Run by
- Brigham and Women's Hospital
See details and how to joinNCT07883720 - No phaseTaking peopleNoninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- Where
- Bethesda
- Age
- 8 years to 120 years
- People
- 700
- Run by
- National Institute of Neurological Disorders and Stroke (NINDS)
See details and how to joinNCT02107989 - Phase 1/2Enrolling by invitationImproving Cardiovascular Health Risks in Adults With Epilepsy on a Modified Atkins Diet
- Where
- Baltimore
- Age
- 18 years and over
- People
- 22
- Run by
- Johns Hopkins University
See details and how to joinNCT06369571 - No phaseTaking peopleSleep-Sensitive Seizure Risk Assessment With Wearable EEGs
- Where
- Durham
- Age
- 18 years and over
- People
- 35
- Run by
- Duke University
See details and how to joinNCT06545643 - No phaseTaking peopleArtificial Intelligence for Brain MRI Analysis in Epilepsy
- Where
- Bethesda, Charleston, Chicago, Oakland, Philadelphia, Washington D.C.
- People
- 2,000 worldwide
- Run by
- Istituto Giannina Gaslini
See details and how to joinNCT07881185 - Early phase 1Taking peopleOptimization of Deep Brain Stimulation Parameters in Patients With Medically Refractory Epilepsy
- Where
- Minneapolis
- Age
- 18 years and over
- People
- 30
- Run by
- University of Minnesota
See details and how to joinNCT05493722 - No phaseTaking peopleOvernight TI in TLE
- Where
- Durham
- Age
- 18 years to 70 years
- People
- 20
- Run by
- Duke University
See details and how to joinNCT07434986 - No phaseTaking peoplePost-Market Real-World Evidence Registry for the NeuroOne OneRF® Ablation System for Epilepsy
- Where
- Livingston, Miami, New Brunswick
- People
- 100
- Run by
- NeuroOne Medical Technologies Corporation
See details and how to joinNCT07546253 - Phase 2Taking peopleA Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of ABS-1230 in Pediatric and Young Adult Participants With KCNT1-related Epilepsy
- Where
- Hackensack, Rochester
- Age
- 1 month to 21 years
- People
- 61
- Run by
- Actio Biosciences, Inc.
See details and how to joinNCT07600736 - No phaseTaking peopleTemporal Interference Brain Stimulation for Adults With Drug-Resistant Epilepsy Undergoing Stereo-EEG Monitoring
- Where
- Durham
- Age
- 18 years and over
- People
- 30
- Run by
- Duke University
See details and how to joinNCT07764718 - No phaseTaking peopleEar-Seizure Detection (EarSD) Study
- Where
- Worcester
- Age
- 18 years and over
- People
- 40
- Run by
- Felicia Chu
See details and how to joinNCT06598189 - Phase 3Enrolling by invitationA Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)
- Where
- Aurora, Austin, Bethesda, Boise, Boston, Gulf Breeze, Houston, Iowa City, Little Rock, Livingston, Los Angeles, Miami, Morristown, New York, Orlando, Palo Alto, Portland, Rochester, San Francisco, Tampa
- Age
- 2 years to 66 years
- People
- 324 worldwide
- Run by
- Longboard Pharmaceuticals
See details and how to joinNCT06908226 · EU 2024-514974-39-00 - No phaseTaking peopleClinical and Electrographic Changes in Responsive Neurostimulation System (RNS) Patients With Acupuncture Treatment
- Where
- Houston
- Age
- 15 years to 60 years
- People
- 10
- Run by
- The University of Texas Health Science Center, Houston
See details and how to joinNCT04677751 - Phase 1/2Taking peopleA First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy
- Where
- Boston, Columbus, Orange, Philadelphia, Rochester
- Age
- 2 years to 12 years
- People
- 20 worldwide
- Run by
- Institut de Recherches Internationales Servier
See details and how to joinNCT07227857 · EU 2024-513332-17-00 - Phase 3Taking peopleAn Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
- Where
- Charlotte, Chicago, Dallas, Detroit, Durham, Houston, Little Rock, Louisville, Marlboro, Miami, Morrisville, New York, Omaha, Orange, Orlando, Philadelphia, Roseville, Salt Lake City, Winter Park
- Age
- 2 years to 55 years
- People
- 260 worldwide
- Run by
- Epygenix
See details and how to joinNCT05066217 - No phaseEnrolling by invitationClinical Utility of Reduced EEG Home Monitoring in Fenfluramine Titration for Dravet and LGS
- Where
- Austin, Louisville, Tacoma
- Age
- 3 years and over
- People
- 20
- Run by
- Byteflies
See details and how to joinNCT07225231 - No phaseTaking peoplePediatric Epilepsy
- Where
- Dallas
- Age
- 3 years to 25 years
- People
- 200
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT07350551